Rie Onodera Selected Research

Stroke (Strokes)

7/2022	Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial.
10/2019	Prevention of neointimal hyperplasia induced by an endovascular stent via intravenous infusion of mesenchymal stem cells.
2/2019	Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
10/2018	Intravenous infusion of mesenchymal stem cells for protection against brainstem infarction in a persistent basilar artery occlusion model in the adult rat.
1/2018	Preservation of interhemispheric cortical connections through corpus callosum following intravenous infusion of mesenchymal stem cells in a rat model of cerebral infarction.
10/2017	Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
11/2016	Synergic Effects of Rehabilitation and Intravenous Infusion of Mesenchymal Stem Cells After Stroke in Rats.
2/2013	Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model.
5/2012	Mesenchymal stem cells: therapeutic outlook for stroke.
6/2011	Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rie Onodera Research Topics

Disease

10	Stroke (Strokes) 07/2022 - 06/2011
4	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 01/2008
4	Cerebral Infarction 02/2019 - 02/2013
4	Chronic Limb-Threatening Ischemia 02/2010 - 08/2007
3	Neutropenia 12/2023 - 11/2017
3	Ischemic Stroke 07/2022 - 10/2017
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2019 - 10/2017
3	Ischemia 02/2010 - 11/2008
3	Thromboangiitis Obliterans (Buerger's Disease) 02/2010 - 11/2008
2	Disease Progression 01/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 11/2016 - 05/2012
2	Pain (Aches) 11/2009 - 11/2008
2	Ulcer 11/2009 - 11/2008
2	Peripheral Arterial Disease 11/2009 - 11/2008
1	Transfusion-Related Acute Lung Injury 12/2023
1	Chronic Brain Injury 07/2022
1	Embolic Stroke 07/2022
1	Atrial Fibrillation 07/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Hyperplasia 10/2019
1	Pathologic Constriction (Stenosis) 10/2019
1	Brain Stem Infarctions (Weber Syndrome) 10/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2017
1	Fibrosis (Cirrhosis) 02/2014
1	Inflammation (Inflammations) 02/2014
1	Adenoma (Adenomas) 02/2014
1	Immunoglobulin G4-Related Disease 02/2014
1	Phlebitis 02/2014
1	Infarction (Infarctions) 06/2011
1	Sensorineural Hearing Loss 11/2010
1	Arteriosclerosis Obliterans 02/2010
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2010
1	Gangrene 02/2010
1	Chronic Granulomatous Disease 12/2009

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 12/2023 - 11/2017
3	AntigensIBA 12/2023 - 11/2017
3	Therapeutic UsesIBA 01/2021 - 05/2012
2	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2018
2	GelatinIBA 11/2010 - 08/2007
2	HydrogelsIBA 11/2010 - 08/2007
2	Troleandomycin (TAO)FDA Link 02/2010 - 11/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2010 - 11/2009
2	Pain-FreeIBA 11/2009 - 11/2008
2	Oxygen (Dioxygen)IBA 11/2009 - 11/2008
1	Dabigatran FDA Link 07/2022
1	RivaroxabanIBA 07/2022
1	apixabanIBA 07/2022
1	AnticoagulantsIBA 07/2022
1	Thrombin FDA Link 07/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2022
1	Factor Xa (Coagulation Factor Xa)IBA 07/2022
1	NeurturinIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2017
1	Immunoglobulin G (IgG)IBA 02/2014
1	Neuroprotective AgentsIBA 05/2012
1	GlucocorticoidsIBA 11/2010
1	Insulin-Like PeptidesIBA 11/2010
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2007

Therapy/Procedure

11	Intravenous Infusions 07/2022 - 02/2013
6	Therapeutics 07/2022 - 11/2008
5	Transplantation 02/2013 - 01/2008
2	Surgical Amputation (Amputations) 02/2010 - 11/2008
2	Cell Transplantation 11/2009 - 11/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2009 - 11/2008
1	Secondary Prevention 07/2022
1	Stents 10/2019
1	Intravenous Administration 06/2011
1	Limb Salvage 02/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2009
1	Intramuscular Injections 11/2008